Fractyl Health (GUTS) Common Equity (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Common Equity data on file, last reported at $21.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 235.33% year-over-year to $21.4 million; the trailing twelve-month figure through Mar 2026 stood at $21.4 million (up 235.33% YoY), and the FY2025 full-year result was $9.5 million, down 66.73% from the prior year.
• Common Equity for Q1 2026 stood at $21.4 million, up from $9.5 million in the prior quarter.
• Across five years, Common Equity topped out at $84.2 million in Q1 2024 and bottomed at -$325.1 million in Q4 2023.
• A 4-year average of -$72.2 million and a median of $6.4 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity plunged 125.74% in 2025 and surged 235.33% in 2026, its largest moves.
• Tracing GUTS's Common Equity over 4 years: stood at -$325.1 million in 2023, then soared by 108.74% to $28.4 million in 2024, then sank by 66.73% to $9.5 million in 2025, then soared by 126.02% to $21.4 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $21.4 million, $9.5 million, and -$3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison